Evidence map›Paper›PMID 39618639›Full record

ArticleCureus2024

Evaluation of the Anti-biofilm Activity of Vitamins Against Acinetobacter baumannii and Klebsiella pneumoniae Recovered From Clinical Specimens: An In Vitro and In Silico Analysis.

Aryan R Ganjo

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Aryan R GanjoDepartment of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, IRQ.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPathogens that form biofilms reduce the effectiveness of conventional treatments and promote antibiotic resistance. Therefore, this study aimed to investigate the antibiofilm properties of vitamin C (ascorbic acid) and vitamin D (cholecalciferol) experimentally.

methodsThe antibiofilm properties of the studied compounds were evaluated using molecular docking analyses. AutoDock Vina software (The Scripps Research Institute, La Jolla, California) was used to assess the binding affinity of vitamins C and D to the active sites of biofilm-related proteins.

resultsMolecular docking revealed different affinities toward the active sites of the target proteins. The interactions showed promising results, with vitamin D forming both hydrogen bonds and hydrophobic interactions. Compared to vitamin C, vitamin D exhibited the highest binding affinity, with a score of -10.8 kcal/mol.

conclusionHowever, molecular dynamics simulations are needed to further elucidate the dynamic behaviors and stability of these compound-protein complexes. Vitamin D demonstrated good in vitro potential as an anti-biofilm agent and should be considered for use alongside antibiotics in the treatment of bacterial infections.

Indexed as

acinetobacter baumanniiascorbic acidautodock vinabiofilmscholecalciferolklebsiella pneumoniae

Identifiers

PMID39618639
PMCPMC11605487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.